Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Cetirizine Dihydrochloride API

Product
  • Therapeutic Category Respiratory

  • CAS Number

    83881-52-1

  • API Technology

    Synthetic

  • Dose Form

    Liquid, Opthalmic, Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF, Egypt DMF

Mechanism of Action

Cetirizine, a metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors.

Indication

Indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Cetirizine Dihydrochloride
Select Regulatory Requirements
Select Purpose

Related APIs

Fexofenadine Hydrochloride (Form 1)

Respiratory

arrow

Montelukast Sodium

Respiratory

arrow

Cetirizine Dihydrochloride

Respiratory

arrow

Levocetirizine Dihydrochloride

Respiratory

arrow

FAQs

What are the uses of Cetirizine Dihydrochloride API?
  • Treats symptoms of allergic rhinitis and chronic idiopathic urticaria

What is the dosage form and strength currently available for Cetirizine Dihydrochloride?
  • Available as oral tablets (5 mg, 10 mg), chewable tablets (5 mg, 10 mg), and oral solution (1 mg/mL)

How do you store Cetirizine Dihydrochloride API?
  • Store at 20°C to 25°C (68°F to 77°F), in a cool, dry place, away from light and moisture

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.